Global Biotech Corp.

EDGAR

Market value is not computed: no recent price is available.

78 filing records in this dataset, filed from 2001-10-15 to 2023-01-18. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-19; this is not a statement that none were filed.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Latest fiscal year

Revenue

312 thousand USD

2013 · USD

Exact inputs and evidence

Operating margin

-119.86%

2013 · %

Exact inputs and evidence
  • Operating Income: -374188 USD Source
  • Revenue: 312200 USD Source

Operating cash flow

32.9 thousand USD

2013 · USD

Exact inputs and evidence
  • Operating Cash Flow: 32895 USD Source
Cash and cash equivalents
Not available
Long-term debt including current maturities
Not available
Shares outstanding
244 million shares Source
Exact value

244038890 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 244038890 shares · 2021-11-30· Source
  • 244038890 shares · 2022-11-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

-63.8 thousand USD

2021-12-01 – 2022-11-30

Exact inputs and evidence
  • Operating cash flow: -12500 USD · 2021-12-01 – 2022-02-28 Source
  • Operating cash flow: -25906 USD · 2021-12-01 – 2022-05-31 Source
  • Operating cash flow: -12500 USD · 2021-12-01 – 2022-02-28 Source
  • Operating cash flow: -45960 USD · 2021-12-01 – 2022-08-31 Source
  • Operating cash flow: -25906 USD · 2021-12-01 – 2022-05-31 Source
  • Operating cash flow: -63764 USD · 2021-12-01 – 2022-11-30 Source
  • Operating cash flow: -45960 USD · 2021-12-01 – 2022-08-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2023-01-18.

Financial data available through: 2022-11-30.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2013-11-30
  • Operating income: 4 of 11 periods available· newest 2022-11-30
  • Net income: 4 of 11 periods available· newest 2022-11-30
  • Operating cash flow: 4 of 11 periods available· newest 2022-11-30
  • capital expenditure: No compatible figures in this window
  • Total assets: 4 of 11 periods available· newest 2022-11-30
  • Total liabilities: 2 of 11 periods available· newest 2022-11-30
  • Current assets: 2 of 11 periods available· newest 2013-11-30
  • Current liabilities: 4 of 11 periods available· newest 2022-11-30
  • cash and cash equivalents: No compatible figures in this window
  • long term debt: No compatible figures in this window
  • Shares outstanding: 4 of 11 periods available· newest 2022-11-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 8,764

    Prior period

    −USD 57,028

    –

    Current period

    −USD 65,792

    –

    Exact inputs and evidence

    -65792 − -57028 = -8764 USD

    -57028 USD · 2020-12-01 – 2021-11-30

    Inspect prior input Prior source

    -65792 USD · 2021-12-01 – 2022-11-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 8,764

    Prior period

    −USD 55,000

    –

    Current period

    −USD 63,764

    –

    Exact inputs and evidence

    -63764 − -55000 = -8764 USD

    -55000 USD · 2020-12-01 – 2021-11-30

    Inspect prior input Prior source

    -63764 USD · 2021-12-01 – 2022-11-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2012-12-01 – 2013-11-30

  • Revenue USD 312,200 100% of revenue
  • Cost of revenue USD 0 0% of revenue
  • Operating expenses USD 686,388 220% of revenue
  • Operating income −USD 374,188 −120% of revenue
  • Tax, interest and other Derived USD 161,498 52% of revenue
  • Net income −USD 535,686 −172% of revenue

Cash

  • Operating cash flow USD 32,895 11% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2013 Operating loss: operating costs were 220% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2013 2012-12-01 – 2013-11-30312200 686388 Derived -374188 161498 Derived -535686 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 312.2K 2013
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.337.2K252.9K168.6K84.3K0.02013
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2013Revenue312200

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2013Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -119.9% 2013
Net margin -171.6% 2013
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.14%-36%-86%-136%-185%2013
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2013Operating margin-119.9%
2013Net margin-171.6%
2013Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD 32.9K 2013
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.35.5K26.6K17.8K8.9K0.02013
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2013Operating cash flow32895

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2013Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2013-11-30Liabilities / assetsNot reported

Current assets to current liabilities

Current assets divided by current liabilities.

0.14× 2013
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.15×0.11×0.07×0.04×0.00×2013
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2013Current assets / current liabilities0.14×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2012 2011-12-01 – 2012-11-30
−USD 392,964
Exact value

Exact value: -392964 USD

2011-12-01 – 2012-11-30: -392964 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 23,670
Exact value

Exact value: -23670 USD

2011-12-01 – 2012-11-30: -23670 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2013 2012-12-01 – 2013-11-30
−USD 535,686
Exact value

Exact value: -535686 USD

2012-12-01 – 2013-11-30: -535686 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 32,895
Exact value

Exact value: 32895 USD

2012-12-01 – 2013-11-30: 32895 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2020-12-01 – 2021-11-30
−USD 57,028
Exact value

Exact value: -57028 USD

2020-12-01 – 2021-11-30: -57028 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 55,000
Exact value

Exact value: -55000 USD

2020-12-01 – 2021-11-30: -55000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2021-12-01 – 2022-11-30
−USD 65,792
Exact value

Exact value: -65792 USD

2021-12-01 – 2022-11-30: -65792 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 63,764
Exact value

Exact value: -63764 USD

2021-12-01 – 2022-11-30: -63764 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

78 filings · 425 latest values · 425 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001126162, 1126162, PURT, edgar:1126162

Also known as Global Biotech Corp., PURTHANOL RESOURCES LIMITED, PURTHANOL RESOURCES LTD., Purthanol Resources Ltd, SWORD COMP SOFT CORP